نتایج جستجو برای: vismodegib

تعداد نتایج: 334  

Journal: :Cancer research 2014
Bin Li Dennis Liang Fei Colin A Flaveny Nadia Dahmane Valérie Baubet Zhiqiang Wang Feng Bai Xin-Hai Pei Jezabel Rodriguez-Blanco Brian Hang Darren Orton Lu Han Baolin Wang Anthony J Capobianco Ethan Lee David J Robbins

The Hedgehog (HH) signaling pathway represents an important class of emerging developmental signaling pathways that play critical roles in the genesis of a large number of human cancers. The pharmaceutical industry is currently focused on developing small molecules targeting Smoothened (Smo), a key signaling effector of the HH pathway that regulates the levels and activity of the Gli family of ...

Journal: :Neurosurgery 2015
Viren Vasudeva John Chi

growth was significantly slowed by MBZ treatment, whereas in untreated controls, tumors extended into the ventricles, resembling the human disease. Overall survival was prolonged by 150% in the SHH allograft model and by 100% in the SHH vismodegib-resistant allograft model. In the group 3 xenograft model, median survival was increased by a striking 129% from 21 to 48 days (P , 1 · 1024; Figure)...

2014
Nancy M. Nix Olivia Burdine Makeda Walker

© 2014 Harborside Press® Skin cancer is the most common cancer type in the United States, affecting more than 3 million people nationally (Cirrone & Harris, 2012). Basal cell carcinoma (BCC) and squamous cell carcinoma are the two main types of nonmelanoma skin cancer, while the more serious form, melanoma, is in its own category. An estimated 80% of nonmelanoma skin cancers are BCCs (Sekulic e...

Journal: :Journal of the Portuguese Society of Dermatology and Venereology 2016

Journal: :Clinical lung cancer 2016
Etienne Giroux Leprieur Thibault Vieira Martine Antoine Nathalie Rozensztajn Nathalie Rabbe Anne-Marie Ruppert Armelle Lavole Jacques Cadranel Marie Wislez

INTRODUCTION Chemoresistance is a major challenge in the treatment of advanced non-small-cell lung cancer (NSCLC). Because the Sonic hedgehog (Shh) pathway is reactivated in NSCLC, we investigated an association between chemoresistance and Shh activation. PATIENTS AND METHODS From a cohort of 178 patients with advanced NSCLC treated with platinum-based chemotherapy as first-line treatment, we...

Journal: :Indian Journal of Dermatology, Venereology and Leprology 2019

2016
Mario E. Lacouture Brigitte Dréno Paolo Antonio Ascierto Reinhard Dummer Nicole Basset-Seguin Kate Fife Scott Ernst Lisa Licitra Rogerio I. Neves Ketty Peris Susana Puig Jonas Sokolof Aleksandar Sekulic Axel Hauschild Rainer Kunstfeld

Abnormal activation of hedgehog pathway signaling is a key driver in the pathogenesis of basal cell carcinoma (BCC). Vismodegib, a first-in-class small-molecule inhibitor of hedgehog pathway signaling, is approved by regulatory authorities for the treatment of adults who have metastatic BCC or locally advanced BCC that has recurred after surgery, or who are not candidates for surgery and who ar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید